Stocks and Investing Stocks and Investing
Tue, May 11, 2021
Mon, May 10, 2021
Fri, May 7, 2021
Thu, May 6, 2021

David Coleman Upgraded (CC) to Strong Buy and Held Target at $40 on, May 6th, 2021


Published on 2024-10-27 16:35:03 - WOPRAI, David Coleman
  Print publication without navigation


David Coleman of Argus Research, Upgraded "The Chemours Company" (CC) to Strong Buy and Held Target at $40 on, May 6th, 2021.

David has made no other calls on CC in the last 4 months.



There are 2 other peers that have a rating on CC. Out of the 2 peers that are also analyzing CC, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Vincent Andrews of "Morgan Stanley" Maintained at Hold with Increased Target to $30 on, Tuesday, February 16th, 2021


This is the rating of the analyst that currently disagrees with David


  • Arun Viswanathan of "RBC Capital" Upgraded from Hold to Buy and Increased Target to $35 on, Friday, January 8th, 2021